Wednesday, February 21, 2024

In the midst of fears about a third wave, there’s good news for kids: the Pfizer vaccine is effective on them

Pfizer claims that its Covid-19 vaccination is effective in children aged five to eleven years old. By the end of this month, the business will petition the Food and Drug Administration for emergency use clearance.

Washington: Despite fears of a third wave of the corona, the wait for a corona vaccination for children may be over. Pfizer claims that trials on children aged 5 to 11 years old were successful. It’s possible that this vaccine will be given to children after receiving approval for emergency use.

Corona will provide protection to children?

Pfizer said on Monday that its Covid-19 vaccination is also effective in youngsters aged five to eleven. In this regard, the corporation will seek approval from the United States. Pfizer’s move is significant in the field of childhood immunization. Pfizer and its German partner BioNTech developed the vaccine, which is now accessible for youngsters aged 12 and up.

Read More: Get your petrol car converts into an electric car, Price of 1 KM would be 74 paise

Children in primary school were used in the study.

Because the onset of the pandemic coincided with the opening of schools, vaccination of children has become more crucial, as the delta variant infection spreads quickly in children, posing a serious threat. Pfizer tested vaccination dosages on primary school children using very modest amounts. This is only a third of the recommended dose. According to Pfizer Senior Vice President Dr. Bill Gruber, after the second dosage of this vaccine, the antibodies combating coronavirus infection in children aged five to eleven years were as robust as those reported in adolescents and youth.

Approval by the Food and Drug Administration is still pending.

Dr. Bill Gruber stated that the amount provided to youngsters has proven to be safe and that they are experiencing the same side effects as teenagers, such as general fever and hand pain. “I believe we’ve arrived at the appropriate location,” said Gruber, a pediatrician. By the end of this month, Gruber said, the business would apply to the Food and Drug Administration for emergency use of the vaccine in children aged five to eleven years. The company will also request permission to use the vaccine with European and British authorities.



Please enter your comment!
Please enter your name here

Most Popular


Covid is again on rise! JN.1 virus is more dangerous than an Omicron

There have been 21 cases of the novel Covid strain, or JN.1, documented. which resulted in the deaths of three Keralans. When it comes...

Covid Cases rises to 10,542! Total Number of Active Cases reaches 63,562

According to data released on Wednesday by the Union Health Ministry, India has recorded 10,542 new Covid Cases, while the number of active cases...

Coronavirus will create a ruckus once more! 3000 new cases found in 24 hrs

Coronavirus once more may spark a public outcry. This apprehension is being expressed because corona cases have once again begun to rise sharply. More...

Booster Dose: According to a British study, the fourth dose of Covid-19 vaccination significantly boosts protection.

Following the initial dosage of Pfizer or AstraZeneca in June 2021, 166 participants were chosen to receive the Pfizer vaccination as the third dose...

Covaxin News: Good news for those taking the foreign vaccine, may get WHO approval in October

Covaxin May Get Approval Soon: SAGE meeting will be held to give final approval to Covaxin. Apart from the scientists of SAGE, representatives of...

Most Popular


* indicates required